Eloxx Pharmaceuticals, Inc. Common Stock

ELOXNASDAQ • USD
13.18 USD
↗ 0.03 (0.23%)🟢PRE MARKET (AS OF 03:59 AM EST)
🟢Market: OPEN

Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) is currently trading at $13.18. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (62.7%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Nov 13, 2026.

Open?$13.18
High?$13.18
Low?$13.18
Prev. Close?$13.15
Volume?0
Avg. Volume?25.2K
Bid / Ask
Bid?$15.64 × 100
Ask?$15.89 × 100
Spread?$0.25
Midpoint?$15.77
Valuation & Ratios
Market Cap?53.1M
Shares Out?4.0M
Float?3.2M
Float %?78.4%
P/E Ratio?N/A
P/B Ratio?-2.35
EPS?-$3.51
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Employees
7
Market Cap
53.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1998-12-11
Address
P.O. BOX 274
ARLINGTON, MA 02476
Phone: 781-577-5300
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
74
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.64Distress
Confidence?39%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.66%Low
Short Interest?52.6K
Days to Cover?2.1
Free Float3.2M
Avg Daily Volume25.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.07Weak
Quick Ratio?0.07Weak
Cash Ratio?0.05Low
Debt/Equity?-0.17Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-2.35CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
93
62.7%STRONG▾
ROA?
S&P
3
-827.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$55.8M
Fundamentals ratios updated end of day